You are searching for: hsa04350

---

T03634 Target Info	Target Name	CREB-binding protein (CREBBP)
	Target type	Clinical trial Target
	Disease	Acute myeloid leukaemia; Solid tumour/cancer;
	Drugs	PRI-724	Drug Info

T23276 Target Info	Target Name	Extracellular signal-regulated kinase 1 (ERK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T22995 Target Info	Target Name	Hepcidin (HAMP)
	Target type	Clinical trial Target
	Disease	Hemochromatosis; Polycythemia vera;
	Drugs	LJPC-401	Drug Info

T40491 Target Info	Target Name	Serine/threonine PP2A-alpha (PPP2CA)
	Target type	Clinical trial Target
	Disease	Molluscum contagiosum infection; Astrocytoma;
	Drugs	VP-102	Drug Info

T49989 Target Info	Target Name	TGF-beta receptor type II (TGFBR2)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	TGF-BR2 mab	Drug Info

T47366 Target Info	Target Name	Activin receptor type IIA (ACVR2A)
	Target type	Clinical trial Target
	Disease	Inclusion body myositis; Acute myeloid leukaemia;
	Drugs	BYM338	Drug Info

T68383 Target Info	Target Name	Bone morphogenetic protein 2 (BMP2)
	Target type	Clinical trial Target
	Disease	Bone development disorder;
	Drugs	DWP-431	Drug Info

T94695 Target Info	Target Name	Mothers against decapentaplegic homolog 7 (SMAD7)
	Target type	Clinical trial Target
	Disease	Crohn disease; Ulcerative colitis;
	Drugs	GED-0301	Drug Info

T99313 Target Info	Target Name	Repulsive guidance molecule A (RGMA)
	Target type	Clinical trial Target
	Disease	Multiple sclerosis; Spinal cord injury;
	Drugs	Elezanumab	Drug Info

T22978 Target Info	Target Name	Transforming growth factor beta 3 (TGFB3)
	Target type	Clinical trial Target
	Disease	Sarcoidosis;
	Drugs	Avotermin	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.